Trt-Olmesartan is a tert-butyloxycarbonyl (Trt)-protected derivative of Olmesartan, featuring a benzimidazole core linked to a tetrazole moiety via a methylene bridge. The Trt group is appended to the amino functionality of the parent compound, forming a carbamate linkage. This impurity arises during synthetic deprotection steps, where incomplete removal of the Trt protecting group occurs. Its structural similarity to Olmesartan enables interference in analytical assays, necessitating its quantification as a critical process-related impurity. Used as an HPLC reference standard for impurity profiling in Olmesartan drug substance characterization.
On RequestCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NN=NN4C(C5=CC=CC=C5)(C6=CC=CC=C6)C7=CC=CC=C7)C(=O)O)C(C)(C)O
InChI=1S/C43H40N6O3/c1-4-16-37-44-39(42(2,3)52)38(41(50)51)48(37)29-30-25-27-31(28-26-30)35-23-14-15-24-36(35)40-45-46-47-49(40)43(32-17-8-5-9-18-32,33-19-10-6-11-20-33)34-21-12-7-13-22-34/h5-15,17-28,52H,4,16,29H2,1-3H3,(H,50,51)
WBRMIXBFMUWHHX-UHFFFAOYSA-N